Eagle
Bio-D (Calcifediol)
$33.00 NZD
60 Tablets
Description
Bio-D contains calcifediol, which is a form of vitamin D3 that is naturally produced in the body by the liver from the precursor colecalciferol. Calcifediol bypasses hydroxylation in the liver, a metabolic step required by colecalciferol. As such, calcifediol only requires one reaction to convert to active vitamin D3.
Indications
• Supports vitamin D levels in the body
• Vitamin D helps calcium absorption and a diet deficient in calcium can lead to osteoporosis in later life
• Maintains muscle function
• Helps to support bone health and bone mineralisation
• Supports healthy teeth and teeth mineralisation
• Supports healthy immune system function
Dosage and Administration
Adults: 1 tablet daily.
The maximum recommended daily dose of calcifediol is 10 micrograms.
Ingredients
| Each tablet contains: | |
| Calcifediol monohydrate | 10 microgram |
Excipients
Calcium hydrogen phosphate dihydrate, croscarmellose sodium, crospovidone, dl-alpha-tocopherol, magnesiumstearate, medium chain triglycerides, microcrystalline cellulose, silicon dioxide, sodium ascorbate, starch sodiumoctenyl succinate, sucrose.
Allergen Information
- No Added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, corn, egg, sesame seeds or artificial colours.
- Vegetarian friendly.
Warnings, Cautions and Contraindications
- Calcifediol may have similar effects of vitamin D. Review patient's medication before prescribing in combination.
- This medicine should not be taken in combination with supplements containing vitamin D without review.
- Use in children under 9 years is not recommended.
- If patient symptoms persist consult, seek additional professional advice.
- Vitamin supplements should not replace a balanced diet.
Get Expert Guidance
Our qualified health practitioners are here to help you choose the right products for your specific health goals, history, and current medications.
Customer Reviews
Frequently Purchased Together
No matching products from this vendor.
